Home LiteratureArticle Details
PMID: 16378982 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Naïve and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy.

Journal of virology ·Vol. 80 ·No. 2 ·2006-01-00 ·Pages 802-9

Ribeiro RM, Hazenberg MD, Perelson AS, Davenport MP

Abstract

Early human immunodeficiency virus infection is characterized by the predominance of CCR5-tropic (R5) virus. However, in many individuals CXCR4-tropic (X4) virus appears in late infection. The reasons for this phenotypic switch are unclear. The patterns of chemokine receptor expression suggest that X4 and R5 viruses have a preferential tropism for naïve and memory T cells, respectively. Since memory cells divide approximately 10 times as often as naïve cells in uninfected individuals, a tropism for memory cells in early infection may provide an advantage. However, with disease progression both naïve and memory cell division frequencies increase, and at low CD4 counts, the naïve cell division frequency approaches that of memory cells. This may provide a basis for the phenotypic switch from R5 to X4 virus observed in late infection. We show that a model of infection using observed values for cell turnover supports this mechanism. The phenotypic switch from R5 to X4 virus occurs at low CD4 counts and is accompanied by a rapid rise in viral load and drop in CD4 count. Thus, low CD4 counts are both a cause and an effect of X4 virus dominance. We also investigate the effects of different antiviral strategies. Surprisingly, these results suggest that both conventional antiretroviral regimens and CCR5 receptor-blocking drugs will promote R5 virus over X4 virus.

MeSH Terms
Anti-HIV Agents/administration & dosage,pharmacology CCR5 Receptor Antagonists CD4 Lymphocyte Count CD4-Positive T-Lymphocytes/immunology,metabolism Cell Division HIV Infections/immunology,therapy HIV-1/physiology Humans Immunologic Memory Models, Immunological Receptors, CCR5/metabolism Receptors, CXCR4/metabolism Time Factors Virus Replication
Chemicals
Anti-HIV Agents CCR5 Receptor Antagonists Receptors, CCR5 Receptors, CXCR4
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Ribeiro Ruy M
Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
Hazenberg Mette D
Perelson Alan S
Davenport Miles P
References (60)
60 references, click to expand
  1. In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline.
    Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1269-74 PMID: 10655520
  2. In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted?
    Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15572-7 PMID: 12434018
  3. Turnover rates of B cells, T cells, and NK cells in simian immunodeficiency virus-infected and uninfected rhesus macaques.
    J Immunol. 2003 Mar 1;170(5):2479-87 PMID: 12594273
  4. Impact of antiretroviral treatment on the tropism of HIV-1 plasma virus populations.
    AIDS. 2003 Apr 11;17(6):809-14 PMID: 12660527
  5. Early viral load and CD4+ T cell count, but not percentage of CCR5+ or CXCR4+ CD4+ T cells, are associated with R5-to-X4 HIV type 1 virus evolution.
    AIDS Res Hum Retroviruses. 2003 May;19(5):389-98 PMID: 12803997
  6. HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection.
    Nature. 2003 Jul 10;424(6945):213-9 PMID: 12853962
  7. Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching.
    J Virol. 2004 Jul;78(14):7565-74 PMID: 15220431
  8. Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses.
    Virology. 2004 Oct 10;328(1):19-29 PMID: 15380354
  9. HIV-1 replication is controlled at the level of T cell activation and proviral integration.
    EMBO J. 1990 May;9(5):1551-60 PMID: 2184033
  10. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.
    Cell. 1990 Apr 20;61(2):213-22 PMID: 2331748
  11. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution.
    J Virol. 1992 Nov;66(11):6777-80 PMID: 1404617
  12. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.
    Ann Intern Med. 1993 May 1;118(9):681-8 PMID: 8096374
  13. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission.
    J Clin Invest. 1994 Nov;94(5):2060-7 PMID: 7962552
  14. In vivo inhibition of syncytium-inducing variants of HIV in patients treated with didanosine.
    AIDS. 1995 Jan;9(1):89-90 PMID: 7893446
  15. In vivo estimates of division and death rates of human T lymphocytes.
    Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3707-11 PMID: 7731969
  16. CD8 naive T cell counts decrease progressively in HIV-infected adults.
    J Clin Invest. 1995 May;95(5):2061-6 PMID: 7738173
  17. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study.
    Nat Med. 1995 Jul;1(7):674-80 PMID: 7585150
  18. Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection.
    J Infect Dis. 1996 Feb;173(2):349-54 PMID: 8568295
  19. Change in coreceptor use correlates with disease progression in HIV-1--infected individuals.
    J Exp Med. 1997 Feb 17;185(4):621-8 PMID: 9034141
  20. Highly purified CD25- resting T cells cannot be infected de novo with HIV-1.
    Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1361-5 PMID: 9037058
  21. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.
    Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1925-30 PMID: 9050881
  22. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens.
    J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Feb 1;14(2):128-35 PMID: 9052721
  23. The bottleneck in AZT activation.
    Nat Med. 1997 Aug;3(8):922-4 PMID: 9256287
  24. HIV phenotype switching during antiretroviral therapy: emergence of saquinavir-resistant strains with less cytopathogenicity.
    AIDS. 1997 Aug;11(10):1211-7 PMID: 9256938
  25. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques.
    Science. 1998 Feb 20;279(5354):1223-7 PMID: 9469816
  26. Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen.
    J Exp Med. 1998 Apr 20;187(8):1295-303 PMID: 9547340
  27. Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection.
    J Virol. 1998 Jun;72(6):5099-107 PMID: 9573281
  28. Increased rates of CD4(+) and CD8(+) T lymphocyte turnover in simian immunodeficiency virus-infected macaques.
    Proc Natl Acad Sci U S A. 1998 May 26;95(11):6388-93 PMID: 9600975
  29. Emergence of syncytium-inducing human immunodeficiency virus type 1 variants coincides with a transient increase in viral RNA level and is an independent predictor for progression to AIDS.
    J Infect Dis. 1998 Aug;178(2):397-403 PMID: 9697719
  30. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals.
    J Immunol. 1998 Sep 15;161(6):3195-201 PMID: 9743388
  31. Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants.
    J Virol. 1999 May;73(5):3544-50 PMID: 10196243
  32. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.
    Annu Rev Immunol. 1999;17:657-700 PMID: 10358771
  33. CD4 T cells remain the major source of HIV-1 during end stage disease.
    AIDS. 1999 Jun 18;13(9):1015-9 PMID: 10397529
  34. Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression.
    J Infect Dis. 1999 Oct;180(4):1106-15 PMID: 10479137
  35. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.
    J Immunol. 1999 Oct 15;163(8):4597-603 PMID: 10510404
  36. Impact of thymectomy on the peripheral T cell pool in rhesus macaques before and after infection with simian immunodeficiency virus.
    Eur J Immunol. 2005 Jan;35(1):46-55 PMID: 15593297
  37. R5 to X4 switch of the predominant HIV-1 population in cellular reservoirs during effective highly active antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):382-92 PMID: 15764954
  38. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.
    Science. 1999 Nov 12;286(5443):1353-7 PMID: 10558989
  39. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).
    Blood. 2000 Jan 1;95(1):249-55 PMID: 10607709
  40. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection.
    Nature. 2005 Apr 28;434(7037):1093-7 PMID: 15793563
  41. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.
    Nature. 2005 Apr 28;434(7037):1148-52 PMID: 15793562
  42. The HIV coreceptor switch: a population dynamical perspective.
    Trends Microbiol. 2005 Jun;13(6):269-77 PMID: 15936659
  43. Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study.
    AIDS. 2000 Jun 16;14(9):1155-61 PMID: 10894279
  44. Cutting edge: naive T cells masquerading as memory cells.
    J Immunol. 2000 Aug 15;165(4):1733-7 PMID: 10925249
  45. Human immunodeficiency virus type 1 induces apoptosis in CD4(+) but not in CD8(+) T cells in ex vivo-infected human lymphoid tissue.
    J Virol. 2000 Sep;74(17):8077-84 PMID: 10933717
  46. The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation.
    J Acquir Immune Defic Syndr. 2000 Nov 1;25(3):203-11 PMID: 11115950
  47. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation.
    J Exp Med. 2000 Aug 21;192(4):557-64 PMID: 10952725
  48. Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy.
    J Clin Invest. 2001 Feb;107(4):431-8 PMID: 11181642
  49. Autologous regulation of naive T cell homeostasis within the T cell compartment.
    J Immunol. 2001 Feb 15;166(4):2460-8 PMID: 11160306
  50. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection.
    J Infect Dis. 2001 Feb 15;183(4):555-62 PMID: 11170980
  51. A potential role for interleukin-7 in T-cell homeostasis.
    Blood. 2001 May 15;97(10):2983-90 PMID: 11342421
  52. Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals.
    J Virol. 2001 Nov;75(21):10319-25 PMID: 11581400
  53. HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues.
    Immunity. 2001 Oct;15(4):671-82 PMID: 11672548
  54. HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use.
    Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):395-400 PMID: 11782552
  55. HIV's response to a CCR5 inhibitor: I'd rather tighten than switch!
    Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1749-51 PMID: 11854476
  56. Both R5 and X4 human immunodeficiency virus type 1 variants persist during prolonged therapy with five antiretroviral drugs.
    J Virol. 2002 Mar;76(6):3054-8 PMID: 11861873
  57. Modelling viral and immune system dynamics.
    Nat Rev Immunol. 2002 Jan;2(1):28-36 PMID: 11905835
  58. Cell turnover and cell tropism in HIV-1 infection.
    Trends Microbiol. 2002 Jun;10(6):275-8 PMID: 12088663
  59. HIV coreceptor usage and drug treatment.
    J Theor Biol. 2002 Aug 21;217(4):443-57 PMID: 12234752
  60. Factors influencing T-cell turnover in HIV-1-seropositive patients.
    J Clin Invest. 2000 Mar;105(5):R1-8 PMID: 10712441
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2006-01-00
Pages
802-9
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC1346847
Subset
IM
Grants
NCRR NIH HHS · RR06555 · United States
NIAID NIH HHS · R37 AI028433 · United States
NIAID NIH HHS · AI28433 · United States
NCRR NIH HHS · RR18754-02 · United States
NIAID NIH HHS · R01 AI028433 · United States
NCRR NIH HHS · R01 RR006555 · United States
NCRR NIH HHS · P20 RR018754 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com